Lawmakers Push DEA to Strengthen Telemedicine Prescribing Rules Before Deadline

A bipartisan group of lawmakers, led by Reps. Doris Matsui and Earl "Buddy" Carter, is advocating for enhancements to the DEA's proposal for a controlled substance registry as the deadline for telemedicine prescribing flexibilities approaches. With concerns about potential exclusions of essential medications, the lawmakers are pressing the DEA to expedite their proposal to ensure continued patient access to telehealth services as pandemic-era flexibilities near expiration. They emphasize the need for compliance with previous Congressional mandates regarding telemedicine prescribing and highlight the urgency for timely actions to prevent disruptions in patient care.

Opens on Healthcare IT News